The Symposium on Advanced Wound Care (SAWC) Fall is the forum to connect the entire wound careteam. Leveraging the skills of an interdisciplinary team results in improved patient outcomes. The SAWC fosters inclusivity, innovation, and interdisciplinary collaboration through an agenda designed for every clinician, across every practice setting. Register Now
15-20 MINUTES – the approximate time it takes to produce a 3C Patch®
18ml of blood is collected into the 3C Patch® device by vacuum. The device is placed into the centrifuge to generate a 3C Patch®.
The blood cells are separated into three layers using a proprietary process controlled by the centrifuge.
The filter is released to compact the leukocytes, platelets and fibrin creating the 3-layer patch.
Histological image highlighting the three layers of the 3C Patch.
Open the device and remove the 3C Patch®.
Place the 3C Patch® filter side up on a sterile absorbing surface.
Apply the filter side (checkered side) of the patch directly to the wound surface. The 3C Patch® may overlap intact skin.
Cover the 3C Patch® with the supplied primary dressing. Apply a secondary absorbent dressing (free choice, depending on the amount of exudate).
The efficacy and regenerative capability of 3C Patch® is supported by solid clinical results, including a large scale randomized controlled trial (RCT) published in the highly recognized medical journal The Lancet Diabetes & Endocrinology in 2018.
The fully automated and integrated centrifugation process offers seamless integration of 3C Patch Wound Management System into the clinic workflow.
18ml blood collection by vacuum
3C Patch® Technology generates a 3C Patch® in a table top centrifuge
Open the device and transfer the 3C Patch® to the wound
Effective April 13, 2021, Medicare covers the 3C Patch® for the treatment of chronic non-healing diabetic wounds for 20 weeks.
1. Game F., Jeffcoate W., Tarnow L., Jacobsen JL., Whitham DJ., Harrison EF., Ellender SJ., Fitzsimmons D., LöndahlM., LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked randomized controlled trial. Lancet Diabetes Endocrinology. 2018; 6(11): 870-878.
2. https://www.cms.gov/Medicare/Coverage/Coverage-with-Evidence-Development/Autologous-Platelet-rich-Plasma, NCT02224742
3. Rayman G., Vas P., Dhatariya K., Driver V., Hartemann A., Londahl M., Piaggesi A., Apelqvist J., Attinger C.,Game F., on behalf of the International Working Group of the Diabetic Foot (IWGDF), IWGDF Guideline on interventions to enhance healing of foot ulcers in persons with diabetes, Part of the 2019 IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease.